Hold at 85-95% weight through Oct 13 binary catalyst; 3-5 day time-stop; re-engage above $397.39
Hold UNH at 85-95% of benchmark weight (light defensive tilt) through the Oct 13 Q3 earnings binary catalyst. The 09-28 binding reflection is dispositive: the asymmetric risk-reward is closer to neutral than to bearish tilt—upside of 6-15% (to $397.39-$430) versus downside of 6-7% (excluding tails) is roughly symmetric in a floor-protected pre-catalyst setup where the 200 SMA at $349.61 has held nine prior tests. Both the research manager's 50-75% Underweight and the trader's SELL overshoot into the failure zone the 09-28 lesson was written to prevent; the Conservative Analyst's 90% (10% defensive trim) is the calibrated response. Execute any future trim AT SPOT, never anchored to overhead resistance. Passive carry past the 3-5 day window is explicitly prohibited. Upgrade to Overweight on: (a) Oct 13 commercial MLR ≤11% AND FY26 guide maintained/raised, OR (b) confirmed close above $397.39 with volume ≥5M and RSI >50 and MACD bullish cross. Downgrade to Sell on: (a) weekly close below $349.61, OR (b) Q3 EPS <$5.50 OR commercial cost trend materially above 11% OR guidance cut OR goodwill impairment disclosure.
| Position | Action |
|---|---|
| Currently above 95% of benchmark weight | Trim 5-10% AT SPOT to land at 90%; do NOT anchor trim to overhead $382-395 resistance (09-22 binding lesson) |
| Currently at 85-95% of benchmark weight | Maintain position unchanged |
| Currently below 85% of benchmark weight | Do not trim further; hold through binary catalyst |
| New positions not currently in portfolio | Do not initiate at spot; wait for confirmed resolution above $397.39 OR capitulation flush to $352-363 (200 SMA structural support) |
The bull case rests on a V-shaped earnings recovery, aggressive debt paydown, and a stealth macro tailwind from elevated interest rates that rewards UNH's float income—all while the stock trades at a discount to historical multiples and its 52-week high.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 376.94 | bearish |
| 50 SMA | 395.60 | bearish |
| 200 SMA | 352.03 | bullish |
| RSI (14) | 40.27 | neutral |
| MACD | -5.86 | bearish |
| MACD Histogram | +0.31 | bullish |
| Bollinger Middle (20 SMA) | 382.45 | neutral |
| Bollinger Lower | 363.50 | neutral |
| Bollinger Upper | 401.40 | neutral |
| ATR | 8.59 | neutral |
Support: 371 · 363.5 · 352.03 | Resistance: 382.45 · 395.6 · 401.4
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Flush to $352-363 where 200 SMA structural support creates asymmetric entry
Then: Consider new/initiate position at capitulation levels
↩ rebuts: “Bear reliance on depressed trailing PE”
EV: +$415+ (prior swing high) · concedes: 50 SMA rolling over represents medium-term headwind; Price below 50 SMA; 6-week pullback within long-term uptrend (bear interprets as bear market); Bad-news discount from 2024-2025 has not fully evaporated
UNH faces structural earnings volatility, goodwill impairment risk (112% of equity), deteriorating sequential momentum (Q1→Q2 EPS –12.5%), and a binary Q3 earnings catalyst within weeks—making current levels a SELL given asymmetric downside to the 200 SMA at $352.
· concedes: Q4 2025 EPS catastrophe ($0.01) was indeed an extreme trough; 24x trailing PE is a valid bearish framing if used in isolation; $9.3B net debt reduction over two quarters is real deleveraging; Q2 2026 OCF of $11.05B was strong on a headline basis; Bollinger lower band at $363.50 has held on multiple tests; The 200 SMA at $352 is a structurally significant floor
→ vs conservative: 200 SMA at $352 cited as support is backward-looking; price action in late August-September also sat above 200 SMA before breaking down; 50 SMA peaked at 412 in mid-August and rolling over for six weeks; real support is $371
→ vs neutral: MACD histogram at +$0.31 is a single bar after weeks of negative readings, signaling slowing decline rate not trend reversal; MACD line at -5.86 vs signal at -6.17, price below 10 EMA; 'neutral' stance is implicitly bullish as holding through binary event with bearish technical stack is functionally an unsized long bet
→ vs conservative: Goodwill at $110.6 billion versus equity of $98.4 billion (over 110% of equity) carries impairment risk not zero; Optum execution questions and Change Healthcare remediation costs could test goodwill; 10-15% impairment equals $10-15 billion permanent capital loss
→ vs conservative: Discount rate math: 16.6x forward multiple with back-loaded terminal value is sensitive to 50bps increase in yields; float tailwind (~$30B at 1% lift) already priced versus 6-12% equity value compression from discount-rate effect
→ vs conservative: Q1 to Q2 EPS decline of 12.5% falsifies 'clean V-shaped recovery'; if Q3 prints below $5.70, the 'attractive valuation' HOLD argument evaporates as multiple expands to 18-22x
UNH is in a technical decision zone at 374.94, with a bearish short-term stack (price < 10 EMA < 50 SMA) but intact long-term bullish structure above the rising 200 SMA at 352.03. The 50 SMA has been declining for ~6 weeks and price is now ~5.2% below it, confirming medium-term breakdown. However, momentum is stabilizing: RSI is neutral at 40.27 (not oversold), MACD histogram just turned positive (+0.31) for the first time since late August, and ATR has compressed from ~12.7 to 8.59. Key levels to watch: resistance at 382.45 (Bollinger middle/20 SMA), 395.60 (50 SMA), and 401.40 (Bollinger upper); support at 371.00 (recent lows), 363.50 (Bollinger lower band ~3% below), and 352.03 (200 SMA structural floor). A confirmed daily close above 382 with rising RSI and sustained positive MACD histogram would shift bias back to bullish; a break below 371 would target 363.50 and potentially 352. The overall rating is HOLD given mixed signals and the absence of confirmed directional triggers.
Market Cap
$336.54B
Trailing PE
24.08x
Forward PE
16.58x
PEG Ratio
1.03
Price / Book
3.45x
EPS (TTM)
$15.57
Forward EPS
$22.61
Dividend Yield
2.46%
Beta
0.622
52-Week High
$461.62
52-Week Low
$255.97
50-Day MA
$398.41
200-Day MA
$355.70
Q4 2025 EPS
$0.01
Q1 2026 EPS
$6.90
Q2 2026 EPS
$6.04
Q2 2026 Revenue
$112.0B
Q2 2026 Operating Income
$7.99B
Q2 2026 Operating Margin
7.1%
Q2 2026 EBITDA
$8.97B
Q2 2026 Net Income
$5.48B
Q2 2026 Operating CF
$11.05B
Q2 2026 FCF
$10.25B
TTM FCF
$24.27B
Q2 2026 Buybacks
$1.65B
Quarterly Dividend
$2.09B
Net Debt
$44.7B
Total Debt
$73.3B
Total Assets
$309.7B
Stockholders' Equity
$98.4B
Debt/Equity
69.2%
Goodwill
$110.6B
Tangible Book Value
-$31.9B
Working Capital
-$25.0B
Current Ratio
0.78
ROE
14.15%
ROA
4.87%
Gross Margin
~20.8%
Net Profit Margin
3.14%
FCF Margin (TTM)
~5.4%
Strengths
Concerns
UnitedHealth Group operates two dominant platforms—UnitedHealthcare (50M+ members across employer, Medicare Advantage, Medicaid, and TRICARE) and Optum (fastest-growing segment covering care delivery, health data/analytics, and pharmacy benefits management)—generating rock-solid ~$112B quarterly revenue. The Q4 2025 earnings shock (EPS $0.01 due to catastrophic MLR spike) was followed by a V-shaped recovery in Q1-Q2 2026 (EPS $6.90 and $6.04 respectively), with Q2 2026 FCF of $10.25B and TTM FCF of ~$24.3B demonstrating exceptional cash generation. The company has aggressively deleveraged $9.3B in net debt over two quarters while maintaining its dividend and resuming buybacks, suggesting strong management confidence and structural earnings power recovery of ~$24-28B annual operating income at normalized margins.
Macro: "Higher-for-longer" rates regime with soft-landing growth: 30Y Treasury at highest level since 2002; 10Y pressing toward 5.5% (45% probability of hitting 5.5% before 2027, +32.2pp one-week move); Fed pricing fully hawkish (96% no cuts in 2026, $8.7M Polymarket volume); mortgage rates at 7.58% near 3-year highs; recession probability anchored at 8% US, 10% UK, 4% Japan; inflation expectations anchored (8% chance >5%, 16% chance >4.5% in 2026); equity markets selling off on yields (Dow/S&P/Nasdaq all down Sep 28); gold at $4,147.70 (+0.27%); tape dominated by tech/AI names (IBM, Palantir, Accenture, Dell, Arista) with no UNH mentions.